Your browser doesn't support javascript.
loading
Non-functional paraganglioma of urinary bladder managed by transurethral resection
Qiao, Baomin; Zhang, Baochao; Fu, Zhenrui; Liu, Liwei; Liu, Chunyu.
  • Qiao, Baomin; Tianjin Medical University. Second Hospital. Tianjin Institute of Urology. Tianjin. CN
  • Zhang, Baochao; Tianjin Medical University. Second Hospital. Tianjin Institute of Urology. Tianjin. CN
  • Fu, Zhenrui; Tianjin Medical University. Second Hospital. Tianjin Institute of Urology. Tianjin. CN
  • Liu, Liwei; Tianjin Medical University. Second Hospital. Tianjin Institute of Urology. Tianjin. CN
  • Liu, Chunyu; Tianjin Medical University. Second Hospital. Tianjin Institute of Urology. Tianjin. CN
Int. braz. j. urol ; 45(5): 910-915, Sept.-Dec. 2019. graf
Article in English | LILACS | ID: biblio-1040086
ABSTRACT
ABSTRACT Purpose As a rare bladder tumor, paraganglioma of the urinary bladder (PUB) is frequently misdiagnosed as bladder cancer, particularly for the non-functional type. To date, transurethral resection remains a controversial treatment for non-functional PUB. This study aimed to identify the clinical features, pathological characteristics, prognosis, and safe/effective treatment of non-functional PUB using transurethral resection of the bladder tumor (TURBT). Materials and Methods The clinical records, radiological data, pathological characteristics and follow-up times were retrospectively reviewed in 10 patients with clinically and pathologically proven non-functional PUB in our hospital from January 2008 to November 2016. All patients underwent TURBT treatment. Results The incidence of non-functional PUB in patients with bladder cancer was 0.17%. The mean age at diagnosis was 44.5 ± 13.6 years (range, 29-70 years), and the patient population had a female male ratio of 3 2. No patients had excess catecholamine (CA) whilst four patients had painless hematuria. All neoplasms were completely resected via TURBT. The majority of samples were positive for immunohistochemical markers including chromogranin A (CgA) and Synaptophysin (Syn), but were negative for cytokeratins (CKs). Only a single recurrence was observed from the mean follow-up period of 36.4 ± 24.8 months. Conclusion Complete TURBT is a safe and efficient treatment that serves both diagnostic and therapeutic purposes. Histopathological and immunohistochemistry examinations are mandatory for diagnostic confirmation. Long-term follow-up is recommended for patients with non-functional PUB.
Subject(s)


Full text: Available Index: LILACS (Americas) Main subject: Paraganglioma / Urinary Bladder Neoplasms Type of study: Observational study / Prognostic study / Risk factors Limits: Adolescent / Adult / Female / Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2019 Type: Article Affiliation country: China Institution/Affiliation country: Tianjin Medical University/CN

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Index: LILACS (Americas) Main subject: Paraganglioma / Urinary Bladder Neoplasms Type of study: Observational study / Prognostic study / Risk factors Limits: Adolescent / Adult / Female / Humans / Male Language: English Journal: Int. braz. j. urol Journal subject: Urology Year: 2019 Type: Article Affiliation country: China Institution/Affiliation country: Tianjin Medical University/CN